New Target for Anti-Malaria Treatments Found
Researchers at NIH and other institutions have discovered another set of pore-like holes, or channels, traversing the membrane-bound sac that encloses the deadliest malaria parasite as it infects red blood cells.
Rapid Test for Gonorrhea Wins $19 Million Prize Competition
A diagnostic test capable of accurately and reliably detecting the microorganism that causes gonorrhea, and rapidly determining in under 30 minutes if the microorganism is susceptible to a single-dose antibiotic, is the winner of the Antimicrobial Resistance (AMR) Diagnostic Challenge.
NIH Researchers Reframe Dog-to-Human Aging Comparisons
One of the most common misconceptions is that 1 human year equals 7 dog years in terms of aging. However, this equivalency is misleading and has been consistently dismissed by veterinarians.
Outdoor Light Linked with Teens’ Sleep, Mental Health
Research shows that adolescents who live in areas that have high levels of artificial light at night tend to get less sleep and are more likely to have a mood disorder relative to teens who live in areas with low levels of night-time light.
Complexity of Tooth Enamel Revealed at Atomic Level
Scientists used advanced microscopy and chemical detection to uncover the structural makeup of tooth enamel at unprecedented atomic resolution, revealing lattice patterns and unexpected irregularities.
Long-Acting Injectable Form of HIV Prevention Outperforms Daily Pill
A PrEP regimen containing an investigational long-acting form of cabotegravir injected was more effective than daily oral Truvada at preventing HIV acquisition in a clinical trial sponsored by NIH.
Gut Bacteria May Modify Behavior in Worms, Influencing Eating Habits
According to a new study in Nature, specific gut bacteria in the worm may modify the animal’s behavior, directing its eating decisions. The research was funded in part by NIH.
Combination of Healthy Lifestyle Traits May Reduce Alzheimer’s Risk
Combining more healthy lifestyle behaviors was associated with substantially lower risk for Alzheimer’s disease in a study that included data from nearly 3,000 research participants.
Hydroxychloroquine Treatment Does No Harm, but Provides No Benefit
A clinical trial to evaluate the safety and effectiveness of hydroxychloroquine for the treatment of adults hospitalized with coronavirus disease 2019 (Covid-19) has been stopped by NIH.